Ahfad University for Women, Omdurman, SudanWe compared the performance of a locally produced b-mercaptoethanol-modified promastigote antigen (b-ME-Ag) of an indigenous Leishmania infantum strain against that of a trypsinized Leishmania donovani reference (REF-Ag) in the direct agglutination test (DAT) for detection of canine visceral leishmaniasis (CVL). One hundred and fifty-one serum samples collected from dogs belonging to four groups with different conditions were included. At a DAT titre of 1 : 320, statistically determined as optimal cut-off value for b-ME-Ag, and 1 : 160 for REF-Ag, a sensitivity and a specificity of 100 % were estimated for b-ME-Ag in comparison with 96.6 % and 100 %, respectively, for REF-Ag. Overall, levels of agglutination titres recorded for the two antigens were highly concordant (Cohen's k50.879) in both the CVL and non-CVL groups. Based on current results, and ease experienced in processing the antigen and reading the test outcome, we recommend incorporation of b-ME-Ag in DAT for confirmation or exclusion of suspected CVL in dogs.
INTRODUCTIONIn the Mediterranean region, visceral leishmaniasis (VL) is a zoonotic disease caused by Leishmania infantum. As in most northern European countries, many people in this region own dogs which, due to optimal habitat, attract phlebotomine flies, increasing the chance of disease transmission to humans and other animals (Gramiccia, 2011). Based on available data, it is assumed that among the existing 15 million dogs residing in southern Europe 2.5 million (16.7 %) are infected with Leishmania (Moreno & Alvar, 2002). Canine visceral leishmaniasis (CVL) seroprevalence rates varying from 1.7 % in southern Cyprus to more than 40 % in southern Italy have been reported (Deplazes et al., 1998;Oliva et al., 2006). More than half of these dogs present asymptomatic Leishmania infection and are thus considered as eligible for transmitting the disease (Molina et al., 1994;Michalsky et al., 2007). Unfortunately, none of the available serological tests has the required efficiency for detecting CVL at the early phase. This shortcoming has urged public health and veterinary authorities to seriously search for tools that are sensitive and reliable for detection of the disease at this phase (Rajasekariah et al., 2008). Establishing diagnostic methods 3Emeritus microbiologist.Abbreviations: (C)VL, (canine) visceral leishmaniasis; DAT, direct agglutination test; b-ME, b-mercaptoethanol.